港股詳情

本页面由TTMF Limited提供服务

華健未來-B待上市

81.800

0.000

成交量：- -

成交額：- -

市值：60.20億

市盈率：- -

高：81.800

開：81.800

低：81.800

收：81.800

52周最高：81.800

52周最低：81.800

股本：7,359.96萬

香港流通股本：7,359.96萬

量比：- -

換手率：- -

股息：- -

股息率：- -

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

市銷率: - -

1

开始申购

06/12

2

申購截止

06/17 10:15

3

公布中签

06/18

4

暗盘

06/22 16:15 - 18:30

5

挂牌上市

06/23

總覽公司新聞公告

价格范围

81.80 ~ 81.80 HKD

发行价

81.80 HKD

发行量

1,360.00萬

预计市值

60.20億 ~ 60.20億 HKD

最低申购数量

100

承销商

中信證券(香港)有限公司

查看招股说明书

新聞

新股消息 | 華健未來-B(06132)招股結束孖展認購額錄得1298億港元超購1166倍

港股公告掘金 | 星源材質和華健未來-B今日起招股

華健未來（成都）科技股份有限公司首發13,600,000股H股，發售價每股81.80港元

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/06132"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"06132","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"06132\",,,,,undefined,":{"symbol":"06132","market":"HK","secType":"STK","nameCN":"華健未來-B","latestPrice":81.8,"timestamp":1781769600000,"preClose":81.8,"halted":9,"volume":0,"delay":0,"changeRate":0,"floatShares":73599600,"shares":73599605,"eps":0,"marketStatus":"待上市","change":0,"latestTime":"06-18 16:00:00","open":81.8,"high":81.8,"low":81.8,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.127,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1782178200000},"marketStatusCode":8,"adr":0,"listingDate":1782144000000,"exchange":"SEHK","adjPreClose":81.8,"openAndCloseTimeList":[[1781746200000,1781755200000],[1781758800000,1781769600000]],"volumeRatio":0,"ipoDetail":{"name":"华健未来－Ｂ","exchange":"SEHK","listingDate":"2026-06-23","sharesOutstanding":73599605,"sharesFloat":73599605,"offerAmount":13600000,"priceRange":"81.800","market":"HK","openProspectusDate":"2026-06-12","openProspectusUrl":"https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0612/2026061200084_c.pdf","purchaseBeginDate":"2026-06-12","purchaseEndDate":"2026-06-17","winningDate":"2026-06-22","currency":"HKD","minPurchaseQuantity":100,"peRate":-40.33,"use":"1、约80.6%或821.3百万港元将用于正在进行及计划中的管线产品临床研究及开发活动提供资金；\n2、约9.4%或95.6百万港元将用于提升研发平台以加强在免疫学、代谢和肿瘤学领域的创新管线，并开拓且开发新临床前药物以加强目前的治疗选项；\n3、约5.0%或50.9百万港元将用于逐步建立商业化团队，并随着候选药物接近商业化而扩大团队，确保产品上市时能有效拓展市场并提供支援；\n4、约5.0%或50.9百万港元将用于一般业务运营及营运资金。","industryId":"204005","industryName":"医疗保健","business":"公司由致力研发自身免疫、代谢及肿瘤学疾病的疗法的行业专家团队创立，透过识别临床需求及从预期结果倒推进行逆向工作，致力提供改良治疗解决方案。","subscribed":1271.26,"marketCap":6020000000,"minimumCapital":8262.49,"overAllotment":true,"lotSize":100,"issueOpenRate":0.1,"subscribeGear":"100,200,300,400,500,600,700,800,900,1000,1500,2000,2500,3000,3500,4000,4500,5000,6000,7000,8000,9000,10000,20000,30000,40000,50000,60000,70000,80000,90000,100000,150000,200000,250000,300000,350000,400000,450000,500000,600000,680000","issueRatio":0.1,"offeringMechanism":"B"},"greyMarketDetail":{"greyDate":"2026-06-22","greyDateTimestamp":1782057600000,"greyOpeningTime":1782116100000,"greyClosingTime":1782124200000,"showGreyQuote":false,"openProspectusDate":"2026-06-12","listingDate":"2026-06-23"},"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"06132\",,,,,undefined,":{"symbol":"06132","floatShares":73599600,"roa":"--","roe":"--","lyrEps":0,"shares":73599605,"dividePrice":0,"high":81.8,"amplitude":0,"preClose":81.8,"low":81.8,"week52Low":81.8,"pbRate":"--","week52High":81.8,"institutionHeld":0,"latestPrice":81.8,"eps":0,"divideRate":0,"volume":0,"delay":0,"ttmEps":-2.127,"open":81.8},"@#url:\"https://hktrade.skytigris.com/ipos/general/06132\",,undefined,":{"id":10127,"type":"COMMON","ipoName":"06132-IPO","symbol":"06132","companyName":"華健未來-B","market":"HK","currency":"HKD","status":"CLOSED","underwriter":"中信證券(香港)有限公司","lotSize":100,"minQty":100,"expectedOfferingSize":13600000,"openingDate":1781227800000,"closingDate":1781662500000,"commonClosingDate":1781662500000,"allotmentDate":1781712000000,"listDate":1782144000000,"marginable":true,"latestPrice":81.8,"minPrice":81.8,"maxPrice":81.8,"allocationPrice":81.8,"prospectusUrl":"https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0612/2026061200084_c.pdf","allowedQuantities":[100,200,300,400,500,600,700,800,900,1000,1500,2000,2500,3000,3500,4000,4500,5000,6000,7000,8000,9000,10000,20000,30000,40000,50000,60000,70000,80000,90000,100000,150000,200000,250000,300000,350000,400000,450000,500000,600000,680000],"recommend":false,"isHint":false,"interestStartDate":1781625600000,"interestEndDate":1781625600000,"delayAllocate":false,"isSupportGreyMarket":true,"greyMarketTradeDate":1782116100000,"transactionRate":0.010085,"gstFeeRate":0,"rank":0,"subscribed":false,"signed":false,"financingInfos":[],"financingNotifyEnabled":false,"financingNotifySubscribed":false,"subscriptionMethods":[],"latestClosingDate":1781841064280,"subscribedFinanceRatio":1271.26,"subscribedRatio":1271.26,"forecastRatio":1639.93,"raiseMoney":111250000,"totalMargin":141426040000,"quoteInfoUpdatedAt":1781840805888,"prospectusUpdatedAt":1781229964000,"forecastMarketValue":6020447689,"minForecastMarketValue":6020447689,"maxForecastMarketValue":6020447689,"sharesOutstanding":73599605,"business":"公司由致力研發自身免疫、代謝及腫瘤學疾病的療法的行業專家團隊創立，透過識別臨床需求及從預期結果倒推進行逆向工作，致力提供改良治療解決方案。","greyOpeningTime":1782116100000,"greyClosingTime":1782124200000,"tradable":false,"showClawback":true,"clawbackType":"機制B","clawbackRate":10},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"06132\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2644713107","title":"新股消息 | 華健未來-B(06132)招股結束 孖展認購額錄得1298億港元 超購1166倍","url":"https://stock-news.laohu8.com/highlight/detail?id=2644713107","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644713107?lang=zh_tw&edition=fundamental","pubTime":"2026-06-17 14:23","pubTimestamp":1781677402,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，生物科技公司华健未来-B于2026年6月12日至6月17日招股，最新已结束招股。根据市场消息，华健未来已获券商借出约1298亿港元孖展，以公开发售集资额1.1亿港元计，超购1166倍。华健未来拟全球发售1360万股H股，其中，香港发售占10%，国际发售占90%，另有超额配股权15%。每股发售价81.80港元，每手100股，一手入场费8262.5港元，集资11.1亿港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1455436.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IPOS","06132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642253343","title":"港股公告掘金 | 星源材質和華健未來-B今日起招股","url":"https://stock-news.laohu8.com/highlight/detail?id=2642253343","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642253343?lang=zh_tw&edition=fundamental","pubTime":"2026-06-12 08:58","pubTimestamp":1781225923,"startTime":"0","endTime":"0","summary":"【重大事项】星源材质(06067)于6月12日至6月17日招股，拟全球发售1.495亿股H股华健未来-B(06132)于6月12日至6月17日招股，拟全球发售1360万股H股佑驾创新(02431)与乐动机器人签署物理AI领域战略合作协议乐动机器人(01236)与佑驾创新签署战略合作协议 聚焦物理AI、具身智能领域开展深度协同乐动机器人(01236)：旗下全球智能割草机器人品牌安思博(ANTHBOT","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1453497.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06132","06067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149230137","title":"華健未來（成都）科技股份有限公司首發13,600,000股H股，發售價每股81.80港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1149230137","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149230137?lang=zh_tw&edition=fundamental","pubTime":"2026-06-12 07:30","pubTimestamp":1781220652,"startTime":"0","endTime":"0","summary":"华健未来（成都）科技股份有限公司成立于2017年，主要从事自身免疫、代谢和肿瘤等领域创新疗法的研究与开发，现有核心产品管线包括HJ787、HJ178、HJ891等，另有HJ356、HJ093、HJ198、HJ086等多款临床前候选药物。截至2024年12月31日止年度，收入约为人民币1,800千元，研发开支约为人民币74,973千元，年内亏损及全面亏损总额约为人民币202,317千元。公司本次全球发售总数为13,600,000股H股，发售价为每股81.80港元，香港公开发售部分为1,360,000股，国际配售部分为12,240,000股。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"华健未来（成都）科技股份有限公司首发13,600,000股H股，发售价每股81.80港元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06132"],"isVideo":false,"video":null,"gpt_icon":1}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":3,"code":"91000000","status":"200"}]}}